Journal
MOLECULAR ONCOLOGY
Volume 6, Issue 6, Pages 683-703Publisher
WILEY
DOI: 10.1016/j.molonc.2012.07.004
Keywords
Epigenetics; Histone demethylases; LSD1; JMJC; Lysine demethylase
Categories
Funding
- Deutsche Forschungsgemeinschaft [Ju295/7-1, Si868/7-1, A04, SFB992]
Ask authors/readers for more resources
Reversible histone methylation has emerged in the last few years as an important mechanism of epigenetic regulation. Histone methyltransferases and demethylases have been identified as contributing factors in the development of several diseases, especially cancer. Therefore, they have been postulated to be new drug targets with high therapeutic potential. Here, we review histone demethylases with a special focus on their potential role in oncology drug discovery. We present an overview over the different classes of enzymes, their biochemistry, selected data on their role in physiology and already available inhibitors. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available